Table 2.
H. pylori eradication rates of each group in PP and ITT analysis.
| Population | Eradication by group (%) | p | |||||
|---|---|---|---|---|---|---|---|
| RMAB | RMMB | RACB | |||||
| Rate n/N (%) | 95% CI | Rate n/N (%) | 95% CI | Rate n/N (%) | 95% CI | ||
| ITT | 102/119 (85.7) | 79.3~92.1 | 91/118 (77.1) | 69.4~84.8 | 86/120 (71.7) | 63.5~79.8 | 0.030∗ |
| PP | 102/114 (89.5) | 83.8~95.2 | 91/108 (84.3) | 77.3~91.2 | 86/112 (76.8) | 68.8~84.7 | 0.036∗∗ |
∗ p = 0.008, RMAB vs. RACB; ∗p = 0.089, RMAB vs. RMMB; ∗p = 0.335, RMMB vs. RACB. ∗∗p = 0.011, RMAB vs. RACB; ∗∗p = 0.250, RMAB vs. RMMB; ∗∗p = 0.163, RMMB vs. RACB. RMAB group: rabeprazole plus minocycline, amoxicillin, and bismuth; RMMB group: rabeprazole plus minocycline, metronidazole, and bismuth; RACB group: rabeprazole plus amoxicillin, clarithromycin, and bismuth. ITT: intention-to-treatment; PP: per-protocol; CI: confidence interval.